Global Lung Cancer Screening Software Market Report 2022: Growing Awareness about Screening Programs Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Dec 2, 2022--

The "Global Lung Cancer Screening Software Market (2022-2027) by Cancer Type, Diagnosis Type, End-Users, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Lung Cancer Screening Software Market is estimated to be USD 2.11 Bn in 2022 and is expected to reach USD 3.26 Bn by 2027, growing at a CAGR of 9.1%

Market Dynamics

Drivers

• Rising Incidences of Lung Cancer
• Growing Awareness about Early-stage Diagnosis

Restraints

• High Cost of Tests

Opportunities

• Growing Awareness about Screening Programs
• Government Initiative to improve Healthcare Infrastructure

Challenges

• Data Privacy and Security Concern

   

Market Segmentations

The Global Lung Cancer Screening Software Market is segmented based on Cancer Type, Diagnosis Type, End-Users, and Geography.

• By Cancer Type, the market is classified into Non-Small Cell Lung Cancer, and Small Cell Lung Cancer.
• By Diagnosis Type, the market is classified into Low Dose Spiral CT Scan and Chest X-Ray.
• By End-Users, the market is classified into Hospitals and Diagnostic Centers.
• By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Lung Cancer Screening Software Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Lung Cancer Screening Software Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Lung Cancer Screening Software Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Lung Cancer Screening Software Market, By Cancer Type

7 Global Lung Cancer Screening Software Market, By Diagnosis Type

8 Global Lung Cancer Screening Software Market, By End-Users

9 Americas' Lung Cancer Screening Software Market

10 Europe's Lung Cancer Screening Software Market

11 Middle East and Africa's Lung Cancer Screening Software Market

12 APAC's Lung Cancer Screening Software Market

13 Competitive Landscape

14 Company Profiles

15 Appendix

Companies Mentioned

• Canon Medical Systems Corp.
• Eon
• GE Company
• Koninklijke Philips N.V.
• MAgView
• Medtronic, PLC
• Nuance Communications, Inc.
• PenRad Technologies, Inc.
• Lungview
• Optellum, Ltd.
• Siemens Healthineers Ag
• Thynk Health, LLC
• Veolity
• Volpara Health, Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/v1nkas.

View source version on businesswire.com:https://www.businesswire.com/news/home/20221202005451/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: SOFTWARE TECHNOLOGY HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2022.